The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Pharmacogenomics in the clinic
Open accessAbstract
After decades of discovery, inherited variations have been identified in approximately 20 genes that affect about 80 medications and are actionable in the clinic. And some somatically acquired genetic variants direct the choice of 'targeted' anticancer drugs for individual patients. Current efforts that focus on the processes required to appropriately act on pharmacogenomic variability in the clinic are moving away from discovery and towards implementation of an evidenced-based strategy for improving the use of medications, thereby providing a cornerstone for precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Pharmacogenomics Knowledge for Personalized Medicine
Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Altman, R. B., & Klein, T. E. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.96 · Cited by 1,796
Shuldiner, A. R. (2009) · JAMA · doi:10.1001/jama.2009.1232 · Cited by 1,505
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., de Boer, A., Oostra, B. A., Lindhout, D., Tytgat, G. N. J., Jansen, P. L. M., Elferink, R. P. J. O., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331802 · Cited by 1,447
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Relling, M. V., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.279 · Cited by 1,164
Self-citationMega, J. L., Simon, T., Collet, J.-P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., et al. (2010) · JAMA · doi:10.1001/jama.2010.1543 · Cited by 1,135
Pharmacogenetics: From Bench to Byte— An Update of Guidelines
Swen, J. J., Nijenhuis, M., de Boer, A., Grandia, L., Maitland-van der Zee, A. H., Mulder, H., Rongen, G. A. P. J. M., van Schaik, R. H. N., Schalekamp, T., Touw, D. J., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.34 · Cited by 1,018
Current Protocols in Human Genetics
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142905 · Cited by 987
Space-Time Relationships in Somesthetic Localization
Jones, F. N. (1956) · Science · doi:10.1126/science.124.3220.484-a · Cited by 836
Genetic Control of Isoniazid Metabolism in Man
Evans, D. A. P., Manley, K. A., & McKusick, V. A. (1960) · BMJ · doi:10.1136/bmj.2.5197.485 · Cited by 784
Moving towards individualized medicine with pharmacogenomics
Evans, W. E., & Relling, M. V. (2004) · Nature · doi:10.1038/nature02626 · Cited by 768
Self-citationYates, C. R., Krynetski, E. Y., Loennechen, T., Fessing, M. Y., Tai, H.-L., Pui, C.-H., Relling, M. V., & Evans, W. E. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-8-199704150-00003 · Cited by 756
Self-citationBeutler, E. (1994) · Blood · doi:10.1182/blood.v84.11.3613.bloodjournal84113613 · Cited by 731
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
Gonzalez, F. J., Skodat, R. C., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., & Meyer, U. A. (1988) · Nature · doi:10.1038/331442a0 · Cited by 715
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future
Gottesman, O., Kuivaniemi, H., Tromp, G., Faucett, W. A., Li, R., Manolio, T. A., Sanderson, S. C., Kannry, J., Zinberg, R., Basford, M. A., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.72 · Cited by 698
Crews, K. R., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Klein, T. E., Caudle, K. E., Haidar, C. E., Shen, D. D., Callaghan, J. T., Sadhasivam, S., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.254 · Cited by 680
Wang, L., McLeod, H. L., & Weinshilboum, R. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1010600 · Cited by 613
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
Yang, S.-K., Hong, M., Baek, J., Choi, H., Zhao, W., Jung, Y., Haritunians, T., Ye, B. D., Kim, K.-J., Park, S. H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3060 · Cited by 549
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, H. M., Crews, K. R., Hoffman, J. M., Caudle, K. E., Broeckel, U., Howard, S. C., Hunkler, R. J., Klein, T. E., Evans, W. E., & Relling, M. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124835 · Cited by 511
Self-citationLook, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B., & Green, A. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110405 · Cited by 491
Kalow, W., & Genest, K. (1957) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/y57-041 · Cited by 465
DRUG REACTIONS, ENZYMES, AND BIOCHEMICAL GENETICS
Motulsky, A. G. (1957) · Journal of the American Medical Association · doi:10.1001/jama.1957.72980250010016 · Cited by 448
Caudle, K., Klein, T., Hoffman, J., Muller, D., Whirl-Carrillo, M., Gong, L., McDonagh, E., Sangkuhl, K., Thorn, C., Schwab, M., et al. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140130124910 · Cited by 446
Self-citationYang, J. J., Landier, W., Yang, W., Liu, C., Hageman, L., Cheng, C., Pei, D., Chen, Y., Crews, K. R., Kornegay, N., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4671 · Cited by 445
Self-citationAdoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
Stanek, E. J., Sanders, C. L., Taber, K. A. J., Khalid, M., Patel, A., Verbrugge, R. R., Agatep, B. C., Aubert, R. E., Epstein, R. S., & Frueh, F. W. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.306 · Cited by 428
Pulley, J. M., Denny, J. C., Peterson, J. F., Bernard, G. R., Vnencak-Jones, C. L., Ramirez, A. H., Delaney, J. T., Bowton, E., Brothers, K., Johnson, K., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.371 · Cited by 414
Pui, C., Crist, W., & Look, A. (1990) · Blood · doi:10.1182/blood.v76.8.1449.1449 · Cited by 373
Finding the Missing Link for Big Biomedical Data
Weber, G. M., Mandl, K. D., & Kohane, I. S. (2014) · JAMA · doi:10.1001/jama.2014.4228 · Cited by 346
Molecular mechanism of slow acetylation of drugs and carcinogens in humans.
Blum, M., Demierre, A., Grant, D. M., Heim, M., & Meyer, U. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5237 · Cited by 343
What is the clinical utility of genetic testing?
Grosse, S. D., & Khoury, M. J. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000227935.26763.c6 · Cited by 303
Bielinski, S. J., Olson, J. E., Pathak, J., Weinshilboum, R. M., Wang, L., Lyke, K. J., Ryu, E., Targonski, P. V., Van Norstrand, M. D., Hathcock, M. A., et al. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.10.021 · Cited by 301
Pharmacogenetics: From Bench to Byte
Swen, J. J., Wilting, I., de Goede, A., Grandia, L., Mulder, H., Touw, D. J., de Boer, A., Conemans, J. M. H., Egberts, T. C. G., Klungel, O. H., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100507 · Cited by 269
Primary care physicians' knowledge of and experience with pharmacogenetic testing
Haga, S., Burke, W., Ginsburg, G., Mills, R., & Agans, R. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01908.x · Cited by 253
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
Hughes, D., & Andersson, D. I. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3922 · Cited by 245
Rasmussen-Torvik, L. J., Stallings, S. C., Gordon, A. S., Almoguera, B., Basford, M. A., Bielinski, S. J., Brautbar, A., Brilliant, M. H., Carrell, D. S., Connolly, J. J., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.137 · Cited by 239
Genomic Medicine: A Decade of Successes, Challenges, and Opportunities
McCarthy, J. J., McLeod, H. L., & Ginsburg, G. S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005785 · Cited by 239
Global implementation of genomic medicine: We are not alone
Manolio, T. A., Abramowicz, M., Al-Mulla, F., Anderson, W., Balling, R., Berger, A. C., Bleyl, S., Chakravarti, A., Chantratita, W., Chisholm, R. L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0194 · Cited by 238
Self-citationMetabolism of isoniazid in man as related to the occurrence of peripheral neuritis.
Hughes, H. B., Biehl, J., Jones, A., & Schmidt, L. H. (1954) · PubMed · doi:10.1164/art.1954.70.2.266 · Cited by 225
Complexities of CYP2D6 gene analysis and interpretation
Gaedigk, A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.825581 · Cited by 224
Genetic Control of Drug Levels in Man: Antipyrine
Vesell, E. S., & Page, J. G. (1968) · Science · doi:10.1126/science.161.3836.72 · Cited by 220
Stocco, G., Cheok, M., Crews, K., Dervieux, T., French, D., Pei, D., Yang, W., Cheng, C., Pui, C.-H., Relling, M., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.154 · Cited by 219
Self-citationCancer pharmacogenomics: strategies and challenges
Wheeler, H. E., Maitland, M. L., Dolan, M. E., Cox, N. J., & Ratain, M. J. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3352 · Cited by 215
Personalizing medicine with clinical pharmacogenetics
Scott, S. A. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e318238b38c · Cited by 211
An overview of FDA-approved new molecular entities: 1827–2013
Kinch, M. S., Haynesworth, A., Kinch, S. L., & Hoyer, D. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.018 · Cited by 210
Development and use of active clinical decision support for preemptive pharmacogenomics
Bell, G. C., Crews, K. R., Wilkinson, M. R., Haidar, C. E., Hicks, J. K., Baker, D. K., Kornegay, N. M., Yang, W., Cross, S. J., Howard, S. C., et al. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001993 · Cited by 208
Self-citationShuldiner, A. R., Relling, M. V., Peterson, J. F., Hicks, K., Freimuth, R. R., Sadee, W., Pereira, N. L., Roden, D. M., Johnson, J. A., & Klein, T. E. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.59 · Cited by 190
Self-citationIrvin, W. J., Walko, C. M., Weck, K. E., Ibrahim, J. G., Chiu, W. K., Dees, E. C., Moore, S. G., Olajide, O. A., Graham, M. L., Canale, S. T., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4427 · Cited by 181
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations
Province, M. A., Goetz, M. P., Brauch, H., Flockhart, D. A., Hebert, J. M., Whaley, R., Suman, V. J., Schroth, W., Winter, S., Zembutsu, H., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.186 · Cited by 175
Phasing Out Fee-for-Service Payment
Schroeder, S. A., & Frist, W. (2013) · New England Journal of Medicine · doi:10.1056/nejmsb1302322 · Cited by 167
Abrams, J., Conley, B., Mooney, M., Zwiebel, J., Chen, A., Welch, J. J., Takebe, N., Malik, S., McShane, L., Korn, E., et al. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.71 · Cited by 159
Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed
McLeod, H. L. (2013) · Science · doi:10.1126/science.1234139 · Cited by 156
Korf, B. R., Berry, A. B., Limson, M., Marian, A. J., Murray, M. F., O’Rourke, P. P., Passamani, E. R., Relling, M. V., Tooker, J., Tsongalis, G. J., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.35 · Cited by 153
Self-citationGottesman, O., Scott, S. A., Ellis, S. B., Overby, C. L., Ludtke, A., Hulot, J., Hall, J. L., Chatani, K., Myers, K., Kannry, J. L., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.72 · Cited by 152
Diverse point mutations in the human gene for polymorphic N-acetyltransferase.
Vatsis, K. P., Martell, K. J., & Weber, W. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6333 · Cited by 152
Pharmacogenomic information in drug labels: European Medicines Agency perspective
Ehmann, F., Caneva, L., Prasad, K., Paulmichl, M., Maliepaard, M., LLerena, A., Ingelman‐Sundberg, M., & Papaluca‐Amati, M. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.86 · Cited by 150
O’Donnell, P. H., Danahey, K., Jacobs, M., Wadhwa, N. R., Yuen, S., Bush, A., Sacro, Y., Sorrentino, M. J., Siegler, M. A., Harper, W., et al. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31385 · Cited by 137
Clinical Analysis and Interpretation of Cancer Genome Data
Allen, E. M. V., Wagle, N., & Levy, M. A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.7215 · Cited by 136
Pharmacogenomic Biomarkers for Prediction of Severe Adverse Drug Reactions
Ingelman‐Sundberg, M. (2008) · New England Journal of Medicine · doi:10.1056/nejme0708842 · Cited by 132
Becquemont, L., Alfirevic, A., Amstutz, U., Brauch, H. B., Jacqz-Aigrain, É., Laurent‐Puig, P., Molina‐Vila, M. Á., Niemi, M., Schwab, M. G., Somogyi, A. A., et al. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.147 · Cited by 116
Johnson, J. A., Burkley, B., Langaee, T. Y., Clare-Salzler, M. J., Klein, T. E., & Altman, R. B. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.125 · Cited by 112
Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions
Chen, Z. Z., Liew, D., & Kwan, P. (2014) · Neurology · doi:10.1212/wnl.0000000000001034 · Cited by 109
Issues Surrounding the Health Economic Evaluation of Genomic Technologies
Buchanan, J., Wordsworth, S., & Schuh, A. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.183 · Cited by 108
Pharmacogenomic Biomarkers for Prediction of Severe Adverse Drug Reactions
(2009) · SciVee · doi:10.4016/10726.01 · Cited by 105
Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters
Brauch, H. B., Schroth, W., Goetz, M. P., Mürdter, T. E., Winter, S., Ingle, J. N., Schwab, M. G., & Eichelbaum, M. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.6625 · Cited by 102
Yeh, P. G., Chen, H., Andrews, J., Naser, R., Pao, W. J., & Horn, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1894 · Cited by 99
Current Protocols in Human Genetics
(2018) · Current Protocols in Human Genetics · doi:10.1002/(issn)1934-8258 · Cited by 97
GORDON, A. S., Tabor, H. K., Johnson, A. D., Snively, B. M., Assimes, T. L., Auer, P. L., Ioannidis, J. P. A., Peters, U., Robinson, J. G., Sucheston, L. E., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt588 · Cited by 88
Rattanavipapong, W., Koopitakkajorn, T., Praditsitthikorn, N., Mahasirimongkol, S., & Teerawattananon, Y. (2013) · Epilepsia · doi:10.1111/epi.12325 · Cited by 83
Oral anticoagulation: a critique of recent advances and controversies
Pirmohamed, M., Kamali, F., Daly, A. K., & Wadelius, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.01.003 · Cited by 82
Bonifaz-Peña, V., Contreras, A. V., Struchiner, C. J., Roela, R. A., Furuya, T. K., Chammas, R. J., Rangel‐Escareño, C., Uribe-Figueroa, L., Gómez-Vázquez, M. J., McLeod, H. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112640 · Cited by 81
Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes
Cheng, Q., Yang, W., Raimondi, S. C., Pui, C., Relling, M. V., & Evans, W. E. (2005) · Nature Genetics · doi:10.1038/ng1612 · Cited by 77
Self-citationeMERGEing progress in genomics—the first seven years
Crawford, D. C., Crosslin, D. R., Tromp, G., Kullo, I. J., Kuivaniemi, H., Hayes, M. G., Denny, J. C., Bush, W. S., Haines, J. L., Roden, D. M., et al. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00184 · Cited by 75
Geneticists push for global data-sharing
Hayden, E. C. (2013) · Nature · doi:10.1038/498017a · Cited by 75
Clinically Available Pharmacogenomics Tests
Flockhart, D. A., Skaar, T. C., Berlin, D. S., Klein, T. E., & Nguyen, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.39 · Cited by 75
Wiener, C. M., Thomas, P. A., Goodspeed, E., Valle, D. L., & Nichols, D. G. (2010) · Academic Medicine · doi:10.1097/acm.0b013e3181ccbebf · Cited by 72
Opportunities for genomic clinical decision support interventions
Overby, C. L., Kohane, I. S., Kannry, J. L., Williams, M. S., Starren, J. B., Böttinger, E. P., Gottesman, O., Denny, J. C., Weng, C., Tarczy-Hornoch, P. Z., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.128 · Cited by 70
The crucial experiment of Wilhelm Johannsen
Roll‐Hansen, N. (1989) · Biology & Philosophy · doi:10.1007/bf02426630 · Cited by 67
Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support
Overby, C. L., Erwin, A., Abul‐Husn, N. S., Ellis, S. B., Scott, S. A., Obeng, A. O., Kannry, J. L., Hripcsak, G. M., Böttinger, E. P., & Gottesman, O. (2014) · Journal of Personalized Medicine · doi:10.3390/jpm4010035 · Cited by 66
Preventing Toxicity With a Gene Test
Marshall, E. (2003) · Science · doi:10.1126/science.302.5645.588 · Cited by 65
Pharmacogenomics: Current State-of-the-Art
Carr, D. F., Alfirevic, A., & Pirmohamed, M. (2014) · Genes · doi:10.3390/genes5020430 · Cited by 52
Brauch, H. B., & Schwab, M. G. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12229 · Cited by 49
Concordance of DMET Plus Genotyping Results With Those of Orthogonal Genotyping Methods
Fernandez, C. A., Smith, C. J., Yang, W., Lorier, R., Crews, K. R., Kornegay, N., Hicks, J. K., Stewart, C. F., Kawedia, J. D., Ramsey, L. B., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.95 · Cited by 49
Self-citationPignatti, F., Ehmann, F., Hemmings, R., Jönsson, B., Nuebling, M., Papaluca‐Amati, M., Posch, M., & Rasi, G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1571 · Cited by 46
Pharmacogenomic Biomarkers in Drug Labels: What Do they Tell Us?
Tutton, R. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.198 · Cited by 42
Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System
Levy, K. D., Decker, B. S., Carpenter, J. S., Flockhart, D. A., Dexter, P. R., Desta, Z., & Skaar, T. C. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.101 · Cited by 39
Clinical Validity and Clinical Utility of Genetic Tests
Burke, W. (2009) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0915s60 · Cited by 37
Beyond the Clinic: ‘Direct-to-Consumer‘ Genomic Profiling Services and Pharmacogenomics
Prainsack, B., & Vayena, E. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.10 · Cited by 35
Role of phenotypic and genetic testing in managing clopidogrel therapy
Chan, N., Eikelboom, J. W., Ginsberg, J. S., Lauw, M. N., Vanassche, T., Weitz, J. I., & Hirsh, J. (2014) · Blood · doi:10.1182/blood-2014-01-512723 · Cited by 35
Leading the way to genomic medicine
Manolio, T. A., & Green, E. D. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31384 · Cited by 30
Dalabira, E., Viennas, E. S., Daki, E., Komianou, A., Bartsakoulia, M., Poulas, K. A., Κάτσιλα, Θ., Tzimas, G. E., & Patrinos, G. P. (2014) · Public Health Genomics · doi:10.1159/000365895 · Cited by 24
Bridging Genomics Research Between Developed and Developing Countries: The Genomic Medicine Alliance
Cooper, D. N., Brand, A. M., Dolžan, V., Fortina, P. M., Innocenti, F., Lee, M. T. M., Maçek, M., Al‐Mulla, F., Prainsack, B., Squassina, A., et al. (2014) · Personalized Medicine · doi:10.2217/pme.14.59 · Cited by 23
An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care
Miñarro-Giménez, J. A., Blagec, K., Boyce, R. D., Adlassnig, K.-P., & Samwald, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093769 · Cited by 21
Zhu, Q., Freimuth, R. R., Lian, Z., Bauer, S., Pathak, J., Tao, C., Durski, M. J., & Chute, C. G. (2012) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2012.11.004 · Cited by 14
Ishiguro, A., Yagi, S., & Uyama, Y. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.36 · Cited by 11
Cited by
Deep learning in cancer diagnosis, prognosis and treatment selection
Tran, K. A., Kondrashova, O., Bradley, A., Williams, E. D., Pearson, J. V., & Waddell, N. (2021) · Genome Medicine · doi:10.1186/s13073-021-00968-x · Cited by 932
Nelson, G., Bakkum-Gamez, J., Kalogera, E., Glaser, G., Altman, A., Meyer, L. A., Taylor, J. S., Iniesta, M., Lasala, J., Mena, G., et al. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000356 · Cited by 758
Pharmacogenomics of GPCR Drug Targets
Hauser, A. S., Chavali, S., Masuho, I., Jahn, L. J., Martemyanov, K. A., Gloriam, D. E., & Babu, M. M. (2018) · Cell · doi:10.1016/j.cell.2017.11.033 · Cited by 616
Caudle, K. E., Dunnenberger, H. M., Freimuth, R. R., Peterson, J. F., Burlison, J. D., Whirl-Carrillo, M., Scott, S. A., Rehm, H. L., Williams, M. S., Klein, T. E., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.87 · Cited by 571
Self-citationPersonalized Medicine and the Power of Electronic Health Records
Abul-Husn, N. S., & Kenny, E. E. (2019) · Cell · doi:10.1016/j.cell.2019.02.039 · Cited by 355
Metadata
- Authors
- Relling, M. V., & Evans, W. E.
- Venue
- Nature
- Published
- 2015-10
- Volume
- 526
- Issue
- 7573
- Pages
- 343-350
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1896195310
- Cited by
- 904
- References
- 96
- FWCI
- 77.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.